Pancreatic Cell News Volume 13.09 | Mar 8 2022

    0
    35







    2022-03-08 | PACN 13.09


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 13.09 – 8 March, 2022
    TOP STORY

    Spatial and Transcriptional Heterogeneity of Pancreatic Beta Cell Neogenesis Revealed by a Time-Resolved Reporter System

    Scientists investigated characteristics of newborn beta cells extracted by a time-resolved reporter system. Single-cell RNA sequencing (scRNA-seq) was performed on mouse beta-cell sorted by fluorescent reporters to uncover transcriptomic profiles of newborn beta cells.
    [Diabetologia]

    Abstract

    Free E-Book: Genome Editing Applications for Disease Modeling and Cell Therapy.
    PUBLICATIONSRanked by the impact factor of the journal

    Physically Interacting Beta-Delta Pairs in the Regenerating Pancreas Revealed by Single-Cell Sequencing

    Scientists utilized sorting of physically interacting cells with single-cell RNA-sequencing to systematically map cellular interactions in the endocrine pancreas after pancreatectomy.
    [Molecular Metabolism]

    AbstractFull Article

    Development of a Scalable Method to Isolate Subsets of Stem Cell-Derived Pancreatic Islet Cells

    The authors described the generation of an array of monoclonal antibodies against cell surface markers that selectively label stem cell-derived islet cells.
    [Stem Cell Reports]

    Full ArticleGraphical Abstract

    Single-Cell Multi-Omics Analysis of Human Pancreatic Islets Reveals Novel Cellular States in Type 1 Diabetes

    Scientists provided a single-cell atlas of pancreatic islets of 24 type 1 diabetes, autoantibody-positive and nondiabetic organ donors across multiple quantitative modalities including ~80,000 cells using single-cell transcriptomics, ~7,000,000 cells using cytometry by time of flight and ~1,000,000 cells using in situ imaging mass cytometry.
    [Nature Metabolism]

    Abstract

    HDAC Class I Inhibitor Domatinostat Sensitizes Pancreatic Cancer to Chemotherapy by Targeting Cancer Stem Cell Compartment via FOXM1 Modulation

    The authors investigated the potential of domatinostat, a new class I histone deacetylase inhibitor, currently in clinical development, to sensitize PDAC to first line standard gemcitabine/taxol doublet chemotherapy treatment.
    [Journal of Experimental & Clinical Cancer Research]

    Full Article

    Pseudogene AK4P1 Promotes Pancreatic Ductal Adenocarcinoma Progression through Relieving miR-375-Mediated YAP1 Degradation

    Scientists characterized a novel pseudogene-miRNA-mRNA network associated with PDAC progression using bioinformatics analysis. After screening by dreamBase and GEPIA, 12 up-regulated and 7 down-regulated differentially expressed pseudogenes were identified.
    [Aging]

    Full Article

    Lucidone Inhibits Autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt Signaling Pathway in Pancreatic Cancer Cells

    Investigators explored the function of lucidone in tumor cytotoxicity and chemosensitivity through the suppression of receptor for advanced glycation end products-initiated signaling in PDAC.
    [Phytotherapy Research]

    Abstract

    Proteomic Analysis Distinguishes Extracellular Vesicles Produced by Cancerous versus Healthy Pancreatic Organoids

    Researchers utilized high resolution flow cytometry to detect EVs in the plasma of patients with pancreatic ductal adenocarcinoma (PDAC) and in the supernatants of PDAC and healthy control pancreatic organoid cultures.
    [Scientific Reports]

    Full Article

    Targeting ASCT2-Mediated Glutamine Metabolism Inhibits Proliferation and Promotes Apoptosis of Pancreatic Cancer Cell

    Scientists showed that alanine serine cysteine‑preferring transporter 2 (ASCT2) expression was significantly higher in pancreatic cancer than in normal pancreatic duct cells and pancreas.
    [Bioscience Reports]

    Abstract

    On-demand Webinar on Studying Cystic Fibrosis using Primary Human Nasal Epithelial Cells - Watch Now
    REVIEWS

    Nanomedicine for Overcoming Therapeutic and Diagnostic Challenges Associated with Pancreatic Cancer

    Nanoparticle drug delivery systems have increased the efficacy of chemotherapeutics by improving the targeting ability of drugs to the tumor site, while also decreasing the risk of local and systemic toxicity.
    [Drug Discovery Today]

    Abstract

    Pancreatic Alpha Cells and Glucagon Secretion: Novel Functions and Targets in Glucose Homeostasis

    Glucagon is often administered to counteract severe hypoglycaemia, and commonly used diabetes medications such as GLP-1 analogues, sulfonylureas and SGLT2-inhibitors also affect alpha cells.
    [Current Opinion in Pharmacology]

    Full Article

    INDUSTRY AND POLICY NEWS

    JDRF Announces Support of Civica to Manufacture and Distribute Low-Cost Insulin

    JDRF, the leading global type 1 diabetes research and advocacy organization, announces a new collaboration with leading diabetes, advocacy, and healthcare partners to support a newly established insulin-centered project from Civica Inc.
    [JDRF, Inc. (BioSpace, Inc.)]

    FEATURED EVENT

    13th Online Dutch Stem Cell Meeting

    April 16, 2022
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Computational Genomics

    Centre for Genomic Regulation – Barcelona, Spain

    Postdoctoral Fellow – Diabetes, Cardiovascular Disorders and Non-Alcoholic Steatohepatitis

    NIH National Heart, Lung, and Blood Institute – Bethesda, Maryland, United States

    Postdoctoral Associate – Liver Cancer

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Position – Pancreatic Beta Cell

    OU Health Sciences Center – Oklahoma City, Oklahoma, United States

    Post-Doctoral Researcher – Anti-Diabetic Drug

    University of Pennsylvania – Philadelphia, Pennsylvania, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter